Opinions
Darren Sissons
Fresenius SE
FRE-GR
COMMENT
Jul 31, 2018
N/A
Stock price when the opinion was issued
0
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick Jul 31/18, Down 34%) Sold it 6 months after picking the stock. Had a big drop in the forth quarter and sold it in a risk management point of view. It's the global leader in kidney diagnosis treatment so the business isn't going away. Still likes the company. If it was to drop a little bit further he would consider buying it back. A good company, just had an unfortunate earnings report during Q4 in December, a really bad timing, if they had it in January we wouldn't have seen that down.
This is the parent of Fresenius Medical, which operates dialysis clinics. The parent company also owns hospitals and a project management business. The dividend has been growing about 12% per year for about 15 years. (Analysts’ price target is €77.36)